These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7819891)

  • 1. Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?
    Lindbäck S; Broström C; Karlsson A; Gaines H
    BMJ; 1994 Dec; 309(6968):1535-7. PubMed ID: 7819891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
    Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
    BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.
    Begtrup K; Melbye M; Biggar RJ; Goedert JJ; Knudsen K; Andersen PK
    Am J Epidemiol; 1997 Apr; 145(7):629-35. PubMed ID: 9098180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of rapid progression to AIDS in HIV-1 seroconverters.
    Keet IP; Krijnen P; Koot M; Lange JM; Miedema F; Goudsmit J; Coutinho RA
    AIDS; 1993 Jan; 7(1):51-7. PubMed ID: 8095146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of three clinical case definitions for advanced HIV disease.
    Gallant JE; Somani J; Chaisson RE; Stanton D; Smith M; Quinn TC
    AIDS; 1992 Mar; 6(3):295-9. PubMed ID: 1348946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
    Phillips AN; Pezzotti P; Lepri AC; Rezza G
    AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters.
    Madec Y; Boufassa F; Porter K; Meyer L;
    AIDS; 2005 Nov; 19(17):2001-7. PubMed ID: 16260907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.
    Hoover DR; Rinaldo C; He Y; Phair J; Fahey J; Graham NM
    AIDS; 1995 Feb; 9(2):145-52. PubMed ID: 7718184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India.
    Srikanth P; Castillo RC; Sridharan G; John TJ; Zachariah A; Mathai D; Schwartz DH
    Int J STD AIDS; 2000 Jan; 11(1):49-51. PubMed ID: 10667901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
    Fernández-Cruz E; Lang JM; Frissen J; Furner V; Châteauvert M; Boucher CA; Dowd P; Stevens J
    AIDS; 1995 Sep; 9(9):1025-35. PubMed ID: 8527074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
    Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
    JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
    Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
    AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?
    Morgan D; Mahe C; Mayanja B; Okongo JM; Lubega R; Whitworth JA
    AIDS; 2002 Mar; 16(4):597-603. PubMed ID: 11873003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.
    Pehrson P; Lindbäck S; Lidman C; Gaines H; Giesecke J
    AIDS; 1997 Jul; 11(8):1007-12. PubMed ID: 9223735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from early, intermediate, and late stages of HIV infection.
    Enger C; Graham N; Peng Y; Chmiel JS; Kingsley LA; Detels R; Muñoz A
    JAMA; 1996 May; 275(17):1329-34. PubMed ID: 8614118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.